ResMed Continues To Build Digital-Medicine Business With $225M Acquisition Of Propeller Health

Propeller Health bills itself as a digital respiratory therapeutics company, providing a mobile platform that communicates with sensors on patients' inhaler devices to help them manage chronic obstructive pulmonary disease and asthma. This the second major acquisition ResMed has announced in the last month.

Asian woman using a pressurized cartridge inhaler extended pharynx, Bronchodilator
• Source: shutterstock.com

ResMed Inc. will make Propeller Health a standalone unit within its Respiratory Care business, augmenting its current lineup of products for chronic obstructive pulmonary disease (COPD), following a $225m acquisition of the privately held Madison, Wisc., company. 

Propeller's "digital medicine platform" is a mobile app that communicates with small sensors attached to inhaler devices used by asthma and COPD patients to track their use of medication while...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business